Subchondral Solutions Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $3M
Latest Deal Amount

Subchondral Solutions General Information

Description

Developer of a biologic implant to allow blood and marrow access to aid in healing the subchondral bone. The company's implant is uniquely designed, chambered, threaded and fenestrated with various sizes to help address most cartilage lesions, enabling patients support for the entire bone-cartilage unit and creation of a healing space for joint restoration.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Primary Office
  • 7146 Edinger Avenue
  • Suite A
  • Huntington Beach, CA 92647
  • United States
+1 (888) 000-0000

Subchondral Solutions Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Subchondral Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 17-Sep-2020 $3M 00.00 0000 Completed Generating Revenue
2. Early Stage VC 17-Oct-2017 000 00.00 000 Completed Startup
1. Early Stage VC (Series A) 01-Jul-2015 $800K $800K 00.00 Completed Startup
To view Subchondral Solutions’s complete valuation and funding history, request access »

Subchondral Solutions Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 1,600,000 $0.001000 $0.04 $0.5 $0.5 1x $0.5 14.09%
To view Subchondral Solutions’s complete cap table history, request access »

Subchondral Solutions Executive Team (6)

Name Title Board Seat Contact Info
Thomas Kinder Chief Executive Officer
Sheryl McCoy Co-Founder & Chief Financial Officer
Chris Maurer Co-Founder & Chief Technology Officer
Thay Lee Ph.D Co-Founder & Chief Science Officer
Derek Dee MD Co-Founder & Chief Medical Officer
You’re viewing 5 of 6 executive team members. Get the full list »